4th Edition of Global Conference on Gynecology & Women's Health
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 4th Edition of Global Conference on Gynecology & Women's Health — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
4th Edition of Global Conference on Gynecology & Women's Health
Date: September 28–30, 2026
Venue: Delta Hotels Heathrow, Ditton Rd, Langley, Slough SL3 8PT, United Kingdom
Event Type: Hybrid (In-person + Virtual)
Event Overview
The 4th Global Conference on Gynecology & Women's Health, organized by Magnus Conferences, will take place from September 28 to 30, 2026, in London, UK, and virtually. Themed "Global Perspectives in Gynecology: Innovation to Impact", this hybrid event offers a premier platform for professionals in women’s health to exchange knowledge, collaborate, and network. Attendees can participate either in person at the Delta Hotels Heathrow or remotely from anywhere in the world.
Scientific Sessions
- Gynecologic Oncology: Screening, Diagnosis & Treatment
- Fertility and Reproductive Medicine
- Assisted Reproductive Technologies (ART) & IVF
- Menopause, Perimenopause, and Hormonal Therapies
- Obstetrics: Prenatal, Perinatal & Postnatal Care
- Pregnancy, Maternal & Fetal Health
- Chronic Pain and Endometriosis Management
- PCOS and Ovulatory Disorders
- Minimally Invasive Gynecologic Surgery
- Urogynecology and Pelvic Floor Disorders
- Mental Health in Women: Perinatal, Postpartum & Menopause
- Artificial Intelligence in Gynecologic Diagnostics
- Sexually Transmitted Infections and Prevention
- Family Planning and Contraceptive Technologies
- Precision Medicine in Gynecology
- Adolescent Gynecology and Young Women’s Health
Key Features
- Keynote presentations and panel discussions
- Interactive workshops and case studies
- Oral and poster sessions for research dissemination
- Live demonstrations of clinical innovations
- Networking opportunities with global experts
- Exhibition of healthcare technologies and services
Target Audience
- Gynecologists
- Obstetricians
- Reproductive Health Specialists
- Researchers and Clinicians
- Nurses and Medical Educators
- Healthcare Innovators
- Policymakers
Registration & Abstract Submission
Early Bird Registration Deadline: June 30, 2026
Abstract Submission Deadline: June 27, 2026
Register or Submit Abstract
Contact Information
Email: gynecology@magnusconference.com
Phone: +1 (702) 988-2320
WhatsApp: +1 (540) 709-1879
Stay Updated
Sign up for conference updates, session reminders, and news:
"We bring together global experts to drive innovation and impact in women's health. Join us to shape the future of gynecology and obstetrics."
Data sheet
4th Edition of Global Conference on Gynecology & Women's Health – Event Attendee & Buyer Profile Analysis
Event date: September 28–30, 2026
Location: Delta Hotels Heathrow Windsor, London, England, United Kingdom
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | 4th Edition of Global Conference on Gynecology & Women's Health |
| Event Date | September 28–30, 2026 |
| Event Status | Upcoming |
| Venue | Delta Hotels Heathrow Windsor |
| City | London |
| State / Region | England |
| Country | United Kingdom |
| Organizer | Magnus Conferences / Magnus Group |
| Official Event Website | gynecology.magnusconferences.com |
| Event Type | Hybrid conference (in-person + virtual) |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Wellness, Health & Fitness; Science & Research; Education & Training |
| Audience Reach | Global primary reach due to hybrid format and explicit international participation messaging |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for total volume; official website confirms event format, theme, audience types, dates, and venue, but not attendee count. |
| Main Purpose of Event | Clinical education, scientific exchange, research presentation, professional networking, and collaboration in gynecology and women’s health. |
About the Event
The 4th Edition of Global Conference on Gynecology & Women's Health is a hybrid medical conference organized by Magnus Conferences and scheduled for September 28–30, 2026 in London, United Kingdom, with virtual participation available worldwide. The official theme, “Global Perspectives in Gynecology: Innovation to Impact,” positions the event as a scientific and professional forum for advancing clinical practice, translational research, and multidisciplinary collaboration across women’s health.
Based on the official event description, the conference is relevant for gynecologists, obstetricians, reproductive health specialists, researchers, clinicians, nurses, medical educators, healthcare innovators, and policymakers. From a commercial and lead-generation standpoint, the event is strongest for organizations selling medical devices, diagnostics, digital health tools, clinical education, hospital solutions, fertility-related technologies, research services, and healthcare partnerships. It is more conference-led than exhibition-led, so buyer discovery is likely to come from speaker, delegate, and institutional outreach rather than from a large published exhibitor floor plan.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Gynecologists and Obstetricians | Hospitals, women’s health clinics, maternity centers, academic medical centers | Clinical decision-makers; influence device, diagnostic, treatment pathway, and training adoption | High relevance for medical devices, diagnostics, surgical tools, digital health, and clinical education suppliers |
| Reproductive Health and Fertility Specialists | IVF clinics, fertility centers, reproductive medicine groups | Buyers or specifiers for ART, IVF, laboratory, patient management, and hormone-related solutions | High relevance for fertility technologies, diagnostics, consumables, and specialist services |
| Researchers and Clinical Scientists | Universities, research institutes, teaching hospitals, translational medicine centers | Influence research collaborations, grants, studies, lab adoption, and publication partnerships | Strong relevance for research platforms, data tools, clinical trials, and academic partnerships |
| Clinicians and Women’s Health Physicians | Specialty practices, outpatient centers, integrated health systems | Treatment adoption, referral influence, protocol selection | Relevant for therapeutics, diagnostics, imaging, telehealth, and patient engagement solutions |
| Nurses and Advanced Practice Professionals | Hospitals, women’s health departments, maternity services | Operational and clinical workflow influence; implementation feedback | Useful for adoption of training, monitoring, workflow, and patient-care tools |
| Medical Educators | Universities, teaching hospitals, CME providers | Influence curriculum, content partnerships, simulation and education technology procurement | Relevant for education platforms, simulation vendors, and scientific publishers |
| Healthcare Innovators and Digital Health Leaders | Health-tech firms, hospital innovation teams, AI diagnostics groups | Partnership, pilot program, and technology evaluation influence | High relevance for AI diagnostics, software, telemedicine, analytics, and interoperability vendors |
| Policymakers and Public Health Stakeholders | Health agencies, public health institutions, policy bodies | Influence policy adoption, maternal health programs, and system-level priorities | Relevant for public-health programs, population health, training, and preventive care initiatives |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: London | Local and metro-area physicians, hospitals, clinics, universities, and health innovators | High | London is a major concentration point for NHS institutions, private healthcare providers, medical research, and international medical travel. |
| Host region: England | Regional clinicians, academic researchers, and healthcare administrators | High | The Heathrow-area venue supports practical access for attendees from across England. |
| Nearby business and clinical hubs | Slough, Greater London, Oxford corridor, and South East England healthcare networks | Medium to High | Strong access to universities, specialist hospitals, life sciences, and medical innovation communities. |
| United Kingdom national reach | Delegates from across the UK including academic medicine and clinical specialties | Medium to High | The official site frames the conference as a professional gathering with broad women’s health relevance. |
| International reach | Global in-person and virtual participants | High | Confirmed by hybrid format and official wording that participation is enabled “from around the world.” |
| Virtual attendance markets | Remote clinicians, researchers, educators, and policymakers worldwide | High | Important for digital lead capture, follow-up, and multi-country Apollo targeting. |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official event is explicitly hybrid and states that it enables participation from around the world. London also strengthens international travel accessibility. |
| National | Secondary practical reach | The UK healthcare, clinical, and academic ecosystem is a likely strong attendance base for in-person participation. |
4. Sample Buyer Companies and Websites
Current-year attendee, buyer, sponsor, exhibitor, and speaker organization lists were not publicly confirmed in the supplied official source text. The table below therefore includes only buyer-side organizations that are strong institutional fits for outreach into this conference market, but their attendance is not confirmed for the 2026 edition.
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| NHS England | Public healthcare system / policy buyer | Relevant to women’s health pathways, maternal services, diagnostics, and population health programs | england.nhs.uk | Clinical Director, Programme Director, Procurement Lead, Digital Health Lead | Strong Market Fit, Attendance Not Confirmed |
| Guy’s and St Thomas’ NHS Foundation Trust | Hospital trust | Major women’s health and maternity provider within London | gstt.nhs.uk | Clinical Director Women’s Health, Consultant Obstetrician, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Imperial College Healthcare NHS Trust | Academic hospital system | Relevant for research, clinical innovation, and women’s health collaboration | imperial.nhs.uk | Research Director, Consultant Gynecologist, Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| University College London Hospitals NHS Foundation Trust | Academic hospital trust | Potential buyer for diagnostics, women’s health research, and specialist clinical solutions | uclh.nhs.uk | Consultant Obstetrician, Service Line Director, Procurement Category Manager | Strong Market Fit, Attendance Not Confirmed |
| King’s College Hospital NHS Foundation Trust | Hospital trust | Relevant women’s and maternal healthcare buyer-side institution | kch.nhs.uk | Head of Women’s Services, Clinical Procurement Lead, Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| The Royal College of Obstetricians and Gynaecologists | Professional body / education stakeholder | Highly relevant to training, standards, and professional engagement in gynecology | rcog.org.uk | Education Director, Clinical Advisor, Partnership Manager | Strong Market Fit, Attendance Not Confirmed |
| Barts Health NHS Trust | Hospital trust | Large London trust with relevant maternity and women’s health service lines | bartshealth.nhs.uk | Director of Midwifery, Women’s Health Lead, Procurement Business Partner | Strong Market Fit, Attendance Not Confirmed |
| Chelsea and Westminster Hospital NHS Foundation Trust | Hospital trust | Relevant for obstetrics, gynecology, fertility-related care, and service improvement | chelwest.nhs.uk | Service Director, Consultant Gynecologist, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| HCA Healthcare UK | Private hospital group | Private-sector women’s health buyer for advanced care, diagnostics, and digital solutions | hcahealthcare.co.uk | Medical Director, Service Line Director, Procurement Category Lead | Strong Market Fit, Attendance Not Confirmed |
| Bupa | Private healthcare provider / payer ecosystem | Relevant for women’s health service networks, care pathways, and digital care access | bupa.com | Clinical Partnerships Director, Innovation Lead, Category Manager | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Clinical Director, Women’s Health | Clinical Operations | Director | Influences service line priorities, care models, and clinical solution adoption |
| 2 | Consultant Gynecologist / Consultant Obstetrician | Clinical | Senior / Practitioner | Strong end-user influence on diagnostics, treatment pathways, and device selection |
| 3 | Head of Obstetrics and Gynecology | Service Line Management | Head / Director | Owns departmental strategy, vendor evaluation, and innovation partnerships |
| 4 | Director of Research / Principal Investigator | Research | Director / Senior | Key for studies, trials, data partnerships, and translational research engagement |
| 5 | Procurement Manager / Category Manager | Procurement | Manager | Important for approved vendor onboarding and healthcare purchasing processes |
| 6 | Medical Director | Executive / Clinical Leadership | Director / Executive | Influences investment, quality standards, and strategic partnerships |
| 7 | Digital Health Lead / Health Innovation Lead | Innovation / IT | Manager / Director | Relevant to AI diagnostics, telemedicine, and software deployment |
| 8 | Director of Midwifery / Nurse Manager | Nursing / Patient Care | Manager / Director | Strong implementation influence over patient-care tools and workflow solutions |
| 9 | Professor / Medical Educator | Education / Academic Affairs | Senior | Valuable for training partnerships, simulation, publishing, and academic dissemination |
| 10 | Program Manager, Women’s Health | Programs / Public Health | Manager | Relevant for grants, public health initiatives, and service implementation |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Primary clinical buyer base for gynecology and women’s health solutions | Hospitals, specialty clinics, maternity and women’s health centers |
| 2 | Medical Devices | Relevant to surgical, diagnostic, monitoring, and fertility-related technologies | Device manufacturers and buyers evaluating new solutions |
| 3 | Pharmaceuticals | Relevant to hormonal therapies, reproductive health, and women’s health therapeutics | Clinical engagement and partnership outreach |
| 4 | Biotechnology | Supports innovation in diagnostics, reproductive medicine, and precision medicine | Research collaboration and product adoption |
| 5 | Research | Conference content is strongly research-led | Academic institutes, clinical research units, translational programs |
| 6 | Higher Education | Relevant for medical schools, educators, and faculty-led research groups | Education, training, partnerships, and sponsored programs |
| 7 | Government Administration | Public health and policy stakeholders are named as attendee types | Maternal health initiatives, public programs, women’s health policy outreach |
| 8 | Health, Wellness & Fitness | Useful for preventive care, menopause, mental health, and women’s wellness services | Broader women’s health solution outreach |
| 9 | Information Technology & Services | Relevant because AI in gynecologic diagnostics is part of the official agenda | Digital health, clinical workflow, data, interoperability, and AI tools |
| 10 | Medical Practice | Private practices and specialist clinics are likely participant groups | Outpatient care, specialist services, fertility and gynecology practices |
| 11 | Education Management | Supports CME, training, conference education, and institutional learning platforms | Academic partnership and professional development targeting |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Official event website text reviewed | No delegate count stated in supplied source set |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Official event website text reviewed | Conference appears content-led; no expo floor or exhibitor directory referenced in supplied text |
| Buyer count | Not publicly confirmed | Unconfirmed | Official event website text reviewed | No procurement or hosted-buyer format disclosed |
| Speaker count | Not publicly confirmed in supplied text | Unconfirmed | Official event website text reviewed | Speaker navigation exists, but no count was provided in the supplied source content |
| Sponsor count | Not publicly confirmed | Unconfirmed | Official event website text reviewed | No sponsor roster provided in supplied text |
| Historical attendance | Historical attendance figure not publicly confirmed in supplied source set | Historical data unavailable | Supplied official text only | Prior editions are referenced, but no verified counts were supplied |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Gynecologic Oncology | Better screening, diagnosis, and treatment pathways | Clinical evidence discussions and specialist partnerships | Diagnostics, imaging, surgical tools, oncology support solutions |
| Fertility and Reproductive Medicine | ART, IVF, reproductive diagnostics, patient pathway optimization | Clinic partnerships and fertility workflow conversations | Fertility tech, lab solutions, hormone management, patient software |
| Maternal & Fetal Health | Improved prenatal, perinatal, and postnatal care | Care model alignment and hospital service line outreach | Monitoring devices, care coordination platforms, training tools |
| Endometriosis, PCOS, and Chronic Conditions | Diagnosis speed, symptom management, long-term care support | Physician education and patient care solution outreach | Diagnostics, therapeutics, remote monitoring, patient engagement |
| Minimally Invasive Gynecologic Surgery | Safer, more efficient surgical procedures | Surgeon and hospital buyer discussions | Surgical instruments, imaging, OR technologies, training simulation |
| AI in Gynecologic Diagnostics | Decision support, workflow efficiency, earlier detection | Innovation pilots and digital health partnership meetings | AI diagnostics, analytics, software integration, clinical data tools |
| Mental Health in Women | Perinatal, postpartum, and menopause-related mental health support | Cross-disciplinary care discussions and program partnerships | Behavioral health integration, screening tools, telehealth support |
| Precision Medicine in Gynecology | Personalized treatment and risk stratification | Research collaborations and specialist physician engagement | Genomics, biomarkers, advanced diagnostics, data platforms |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Relevant for clinical, research, digital health, and healthcare institutional buyers in women’s health. |
| Decision-maker availability | Medium | Clinical leaders are likely present, but a pure procurement-led buyer program is not indicated. |
| Data collection potential | Medium | Good for speaker/delegate/institutional prospecting, but current-year attendee data is not publicly posted in the supplied source set. |
| Apollo targeting potential | Very High | Clear industry, role, and keyword mapping exists across hospitals, research, medical devices, and digital health. |
| Geographic targeting potential | High | Strong fit for UK, Europe, and global remote-attendee targeting due to hybrid format. |
| Best outreach approach | High | Use account-based outreach to women’s health service lines, clinical leaders, research heads, and innovation teams. |
| Overall lead quality | High | Strong fit for specialized healthcare offerings; less ideal for mass attendee-list extraction without additional official participant disclosures. |
| Best use case | High | B2B outreach into hospitals, fertility centers, academic medicine, public health, and digital health partnerships. |
| Limitations / risks | Medium | Event appears conference-centric rather than a large trade show; public buyer/exhibitor counts and named attendee organizations are limited. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Government Administration; Health, Wellness & Fitness; Information Technology & Services; Medical Practice | Covers the most likely clinical, research, policy, and digital health participants |
| Departments | Clinical Operations; Research; Medical; Procurement; Innovation; Information Technology; Nursing; Academic Affairs; Partnerships | Targets both end users and institutional influencers |
| Seniority | Manager; Director; VP; CXO; Partner; Owner; Head; Senior | Improves access to decision-makers and strategic influencers |
| Job titles | Clinical Director, Medical Director, Consultant Gynecologist, Consultant Obstetrician, Head of Women’s Health, Director of Midwifery, Procurement Manager, Category Manager, Research Director, Principal Investigator, Health Innovation Lead, Digital Health Lead, Professor of Obstetrics and Gynecology | Targets direct users, service line leaders, and approval stakeholders |
| Geography | United Kingdom first; then Ireland, Western Europe, North America, Middle East, and APAC for hybrid participation coverage | Reflects London venue plus virtual global reach |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Captures specialist clinics through to major hospital systems and research institutions |
| Keywords | gynecology, obstetrics, women’s health, maternal health, fetal medicine, reproductive medicine, fertility, IVF, endometriosis, PCOS, urogynecology, menopause, pelvic floor, maternal mental health, gynecologic oncology, AI diagnostics | Improves event-theme alignment inside broad healthcare accounts |
| Technologies, if relevant | AI diagnostics, telehealth, EHR integration, clinical analytics, fertility lab systems | Useful for digital health and clinical innovation solutions |
| Revenue range, if relevant | Mid-market to enterprise healthcare organizations | Best for buyers with formal budgets and institutional procurement structures |
| Company type | Hospitals, academic medical centers, fertility clinics, research institutes, government health bodies, private healthcare groups, digital health organizations | Narrowing by operating model improves campaign precision |
Suggested Apollo Search Logic: ("gynecology" OR "gynaecology" OR "women's health" OR "womens health" OR obstetrics OR fertility OR IVF OR endometriosis OR PCOS OR urogynecology OR menopause OR "maternal health") AND (Director OR Head OR Consultant OR Medical OR Procurement OR Innovation OR Research).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Gynecology Conferences 2026 | Womens Health Conference | Official event website | Event name, dates, hybrid format, city, country, venue name, venue address, theme, audience profile, and scientific sessions | High |
| Official event website navigation and page content supplied by user | Primary source text extract | Confirmed absence, in the supplied source set, of publicly posted attendee counts, exhibitor counts, sponsor roster, and speaker count | High for negative verification within supplied source set |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 4th Edition of Global Conference on Gynecology & Women's Health — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds